Table 1 Demographics and clinical characteristics of enrolled patients.
 | PCR COVID-19 | P Value | |
---|---|---|---|
Positive | Negative | ||
n (%) | n (%) | ||
Gender | |||
 Male | 79 (27.6%) | 207 (72.4%) | 0.509 |
 Female | 79 (25.2%) | 234 (74.8%) |  |
Age Groups | |||
 0–15 Years | 9 (6.7%) | 125 (93.3%) | 0.000* |
 15–40 Years | 49 (24.6%) | 150 (75.4%) |  |
 40–60 Years | 52 (36.6%) | 90 (63.4%) |  |
 Above 60 Years | 48 (36.7%) | 76 (61.3%) |  |
Symptoms | |||
 Fever | 99 (28.4%) | 250 (71.6%) | 0.192 |
 Cough | 126 (25.9%) | 361 (74.1%) | 0.559 |
 Dyspnea | 102 (25.7%) | 295 (74.3%) | 0.594 |
 Diarrhea | 50 (27.6%) | 131 (72.4%) | 0.649 |
 Loss of smell | 51 (31.3%) | 112 (68.7%) | 0.095 |
 Loss of taste | 48 (31.4%) | 105 (68.6%) | 0.104 |
 Runny nose | 59 (21.7%) | 213 (78.3%) | 0.018* |
 Sore throat | 68 (26.2%) | 192 (73.8%) | 0.913 |
Comorbidity | 90 (32.4%) | 188 (67.6%) | 0.002* |
 Vascular event | 19 (22.1%) | 67 (77.9%) | 0.330 |
 Neurological event | 11 (18.3%) | 49 (81.7%) | 0.136 |
 Hypertension | 35 (40.7%) | 51 (59.3%) | 0.001* |
 Diabetes | 29 (38.7%) | 46 (61.3%) | 0.010* |
 Chronic cardiac disease | 18 (24%) | 57 (76%) | 0.617 |
 Asthma | 15 (25%) | 45 (75%) | 0.799 |
 Chronic respiratory disease | 11 (23.4%) | 36 (76.6%) | 0.630 |
 Obesity | 8 (32%) | 17 (68%) | 0.515 |
 Chronic liver disease | 7 (41.2%) | 10 (58.8%) | 0.16 |
 Chronic neurological disease | 7 (50%) | 7 (50%) | 0.042* |
 Chronic renal disease | 3 25%) | 9 (75%) | 0.913 |
 Chronic hematological disorder | 3 (30%) | 7 (70%) | 0.793 |
 Pregnant | 1 (11.1%) | 8 (88.9%) | 0.295 |
 Seasonal Influenza vaccination in last 6 months | 2 (25%) | 6 (75%) | 0.929 |
 Immunodeficiency | 2 (33.3%) | 4 (66.7%) | 0.698 |